North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,310 Jan 1 – Oct 27, 2026
- Disclosed funding
- $252.1B 1915 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B Provides AI-powered voice coaching for non-native English speakers | $21M | Series A | Edtech | United States | Investors | |
| O OuttakeCompany profile Provides a unified platform for digital trust to detect, investigate, and disrupt identity-based ... Provides a unified platform for digital trust to detect, investigate, and disrupt identity-based ... | $40M | Series B | Cybersecurity | United States | Investors | |
 CellaresCompany profile Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network. Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network. | $257M | Series DSeries C+ | Biotech | United States | Investors | |
| C CheckboxCompany profile Provides AI-powered legal intake and workflow automation for in-house legal teams Provides AI-powered legal intake and workflow automation for in-house legal teams | $23M | Series A | Enterprise software | United States | Investors | |
 Adaptive6Company profile Adaptive6 helps enterprise engineering and FinOps teams find, fix and prevent waste in cloud infrastructure and AI workloads. Adaptive6 helps enterprise engineering and FinOps teams find, fix and prevent waste in cloud infrastructure and AI workloads. | $28M | Series A | Developer tools | United States | Investors | |
| CT CraniUS TherapeuticsCompany profile Develops implantable platform to bypass blood-brain barrier for drug delivery Develops implantable platform to bypass blood-brain barrier for drug delivery | $20M | Series B | Healthtech | United States | Investors Undisclosed | |
| O OriginCompany profile Provides pelvic floor physical therapy and whole-body musculoskeletal care for women Provides pelvic floor physical therapy and whole-body musculoskeletal care for women | Undisclosed | Series B | Healthtech | United States | Investors | |
| SB Stellular BioCompany profile Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases | Undisclosed | Series A | Biotech | United States | Investors | |
| CT Curate TechnologiesCompany profile Provides white-labeled no-download mobile ordering and loyalty experiences for restaurants Provides white-labeled no-download mobile ordering and loyalty experiences for restaurants | $10M | Undisclosed | Foodtech | United States | Investors | |
 AON3DCompany profile AON3D supplies industrial 3D printers, software and materials for manufacturers producing high-performance polymer components. AON3D supplies industrial 3D printers, software and materials for manufacturers producing high-performance polymer components. | Undisclosed | InvestmentUndisclosed | Industrial tech | Canada | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Provision Labs, Tractian, Different
71rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.